Edmond de Rothschild Holding’s Novavax NVAX Stock Holding History

Edmond de Rothschild Holding’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-83	Closed	-$12K	–	839
2021 Q4	$12K	Sell	83 -17	-17%	-$2.92K	﹤0.01%	786
2021 Q3	$21K	Buy	+100	New	+$22K	﹤0.01%	749
2019 Q2	–	Sell	-76,857	Closed	-$847K	–	617
2019 Q1	$847K	Buy	76,857 +35,688	+87%	+$1.13M	0.03%	249
2018 Q4	$1.51M	Hold	41,169	–	–	0.05%	203
2018 Q3	$1.55M	Hold	41,169	–	–	0.04%	228
2018 Q2	$1.1M	Hold	41,169	–	–	0.03%	253
2018 Q1	$1.73M	Sell	41,169 -10,000	-20%	-$402K	0.05%	212
2017 Q4	$1.27M	Buy	51,169 +15,000	+41%	+$366K	0.04%	242
2017 Q3	$832K	Buy	+36,169	New	+$810K	0.02%	295

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Edmond de Rothschild Holding's NVAX Position: Q1 2022 in Review

Edmond de Rothschild Holding sold out of Novavax (NVAX) in Q1 2022, closing a stake of 83 shares — an estimated $12K sold.

Edmond de Rothschild Holding first reported a position in NVAX in Q3 2017 and held it in 9 quarters. The position peaked at $1.73M in Q1 2018. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

Edmond de Rothschild Holding reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
Edmond de Rothschild Holding sold 83 Novavax shares in Q1 2022, an estimated $12K.
Edmond de Rothschild Holding first reported a position in Novavax in Q3 2017 and held it in 9 quarters.
Edmond de Rothschild Holding's Novavax position peaked at $1.73M in Q1 2018.
381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Edmond de Rothschild Holding's 13F filing for Q1 2022, filed 10 May 2022.